NM_001161352.2(KCNMA1):c.16G>A (p.Gly6Ser) AND Generalized epilepsy-paroxysmal dyskinesia syndrome
- Germline classification:
- Uncertain significance (1 submission)
- Last evaluated:
- Nov 16, 2022
- Review status:
- Somatic classification
of clinical impact: - None
- Review status:
- Somatic classification
of oncogenicity: - None
- Review status:
- Record status:
- current
- Accession:
- RCV000639889.11
Allele description [Variation Report for NM_001161352.2(KCNMA1):c.16G>A (p.Gly6Ser)]
NM_001161352.2(KCNMA1):c.16G>A (p.Gly6Ser)
Condition(s)
Assertion and evidence details
Last Updated: Aug 4, 2024